BioNote, Inc. (KRX:377740)
South Korea · Delayed Price · Currency is KRW 5,820.00
-10.00 (-0.17%)
Last updated: Feb 20, 2026, 2:39 PM KST
BioNote Market Cap
BioNote has a market cap or net worth of 592.96 billion as of February 20, 2026. Its market cap has increased by 19.92% in one year.
Market Cap
592.96B
Enterprise Value
246.49B
Revenue
115.09B
Ranking
n/a
PE Ratio
5.04
Stock Price
5,820.00
Market Cap Chart
Since December 22, 2022, BioNote's market cap has decreased from 1.08T to 592.96B, a decrease of -45.35%. That is a compound annual growth rate of -17.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 592.96B | 6.95% |
| Dec 30, 2025 | 554.45B | 15.35% |
| Dec 30, 2024 | 480.68B | 10.95% |
| Dec 28, 2023 | 433.23B | -50.44% |
| Dec 29, 2022 | 874.10B | -19.44% |
| Dec 22, 2022 | 1.08T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CLASSYS | 4.60T |
| T&L Co., Ltd. | 447.19B |
| Value Added Technology | 327.54B |
| Vieworks | 231.27B |
| Dongbang Medical | 173.12B |
| Shinhung | 127.40B |
| EOFLOW | 51.11B |
| PCL, Inc. | 17.87B |